Weill Cornell Medicine - Cutaneous Oncology and Melanoma Program — New York, New York

Weill Cornell Medicine - Cutaneous Oncology and Melanoma Program is a clinical research site located in New York, New York, United States 10065.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Weill Cornell Medicine - Cutaneous Oncology and Melanoma Program has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Small-cell Lung Cancer, Neuroendocrine Carcinomas, Solid Tumor Show to Express DLL3.

Sponsors: IDEAYA Biosciences.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Weill Cornell Medicine - Cutaneous Oncology and Melanoma Program?

Weill Cornell Medicine - Cutaneous Oncology and Melanoma Program has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Weill Cornell Medicine - Cutaneous Oncology and Melanoma Program conducted?

Weill Cornell Medicine - Cutaneous Oncology and Melanoma Program has 1 clinical trials on record, with 1 currently active. Their work covers Small-cell Lung Cancer, Neuroendocrine Carcinomas, Solid Tumor Show to Express DLL3.

Is Weill Cornell Medicine - Cutaneous Oncology and Melanoma Program accredited by Crixeo Health?

Weill Cornell Medicine - Cutaneous Oncology and Melanoma Program has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Weill Cornell Medicine - Cutaneous Oncology and Melanoma Program?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.